article · Sudan Journal of Medical Sciences
Background: Triple A syndrome (TAS), also referred to as Allgrove Syndrome (AS), is a rare inherited multisystem disorder. Mutations in the AAAS gene, which encodes the nuclear pore complex protein ALADIN, are responsible for this syndrome, named for its main features of (ALacrima, Achalasia, ADrenal Insufficiency, and Neurological disorder). Absence of tears (alacrima), the earliest clinical manifestation of this syndrome, is frequently overlooked, leading to significant delays in clinical recognition. Case Report: We report a young female child who presented late with features suggestive of severe adrenal crisis secondary to primary adrenal insufficiency (PAI). She was born to first-degree relatives who had three deceased siblings with similar presentations, all of whom presumably died from untreated adrenal crises. Alacrima had been present in all siblings since birth and served as the key diagnostic clue in this case, enabling early recognition and appropriate life-saving intervention. The clinical presentation of TAS is highly heterogeneous, and early signs are nonspecific, which often contributes to diagnostic uncertainty and delays or missed diagnoses. In a country with limited resources for specific testing and inaccessible genetic diagnosis, such as Sudan, diagnosis relies primarily on careful clinical evaluation to identify key phenotypic features that eventually lead to accurate and timely diagnosis and management. Conclusion: This case report underscores the importance of clinical awareness in the identification and timely management of TAS. It also highlights the critical role of careful clinical evaluation, particularly in children presenting with absence of tears, hyperpigmentation, and recurrent hypoglycemia, to facilitate early identification of cases and prevent life-threatening outcomes.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.18502/sjms.v21i2.20709
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.